CXCL8 and infectious colitis: Such host–pathogen interaction at the colonic mucosa resulted in the production of the neutrophil chemoattractant CXCL8 (humans)/CXCL1 (mice) and pathogen clearance, representing a novel endogenous innate cathelicidin defense in the setting of infectious colitis.